Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes-Reference-Cited by-同舟云学术

Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes

Published:2014-07-27 Issue:4 Volume:16 Page:1036-1045
ISSN:1470-3203
Container-title:Journal of the Renin-Angiotensin-Aldosterone System
language:en
Short-container-title:J Renin Angiotensin Aldosterone Syst

Author:

Færch Louise H¹,Thorsteinsson Birger¹²,Tarnow Lise³⁴,Holst Jens Juul⁵,Kjær Troels⁶,Kanters Jørgen⁷⁸,Larroude Charlotte⁸⁹,Dela Flemming¹⁰,Pedersen-Bjergaard Ulrik¹²

Affiliation:

1. Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Hillerød, Denmark

2. Department of Clinical Medicine, University of Copenhagen, Denmark

3. HIH Research Unit, Nordsjællands Hospital – Hillerød, Denmark

4. Department of Health, University of Aarhus, Denmark

5. NNF Centre for Basic Metabolic Research, Department of Biomedical Sciences, the Panum Institute, University of Copenhagen, Denmark

6. Clinic of Neurophysiology, The Neuroscience Centre, Rigshospitalet, Copenhagen University Hospital, Denmark

7. Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Denmark

8. Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Frederikssund, Denmark

9. Department of Cardiology, Bispebjerg Hospital, Copenhagen, Denmark

10. Xlab, Centre for Healthy Ageing, University of Copenhagen, Denmark

Publisher

Hindawi Limited

Subject

Endocrinology,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1470320314529356

Reference31 articles.

1. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus

2. Prediction of Severe Hypoglycaemia by Angiotensin-Converting Enzyme Activity and Genotype in Type 1 Diabetes